Lung Adenocarcinoma with Paraneoplastic Hyper-Eosinophilia Not Responding To Pembrolizumab

BACKGROUND: Paraneoplastic hyper-eosinophilia associated with metastatic lung adenocarcinoma is a rare finding and has been associated with a poor prognosis when present. Early hyper-eosinophilia appearing following non-small cell lung cancer (NSCLC) treatment with immune checkpoint inhibitors (ICI)...

Descripción completa

Detalles Bibliográficos
Autores principales: Wehbe, Hisham, Kozah, Maria, Koubaissi, Salwa A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8327228/
https://www.ncbi.nlm.nih.gov/pubmed/34377046
http://dx.doi.org/10.1177/11795484211030164

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8327228/
https://www.ncbi.nlm.nih.gov/pubmed/34377046
http://dx.doi.org/10.1177/11795484211030164

Ejemplares similares